Literature DB >> 17434814

Group sequential t-test for clinical trials with small sample sizes across stages.

Jun Shao1, Huaibao Feng.   

Abstract

Interim analyses are often applied in clinical trials for various reasons. To assess the effect of a clinical treatment, the group sequential t-test with a fixed number of interim analyses is frequently used in clinical trials. The existing critical values used in group sequential t-tests are obtained from normal approximations of t-statistics. In practice, however, normal approximation is not accurate when some sample sizes of treatment arms in some stages are small. In this paper, instead of using normal approximation, we directly obtain the critical values via a Monte Carlo method. We list some critical values for certain sample sizes and number of interim analyses, and provide some SAS code for general situations. We also consider the sample size calculation and run some simulations to check the accuracy of our critical values. The simulation results show that our critical values yield type I error probabilities that are very close to the nominal significance level, whereas the existing critical values based on normal approximation are not accurate when some sample sizes are small across stages.

Entities:  

Mesh:

Year:  2007        PMID: 17434814     DOI: 10.1016/j.cct.2007.02.006

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  4 in total

1.  Optimal multistage designs for randomised clinical trials with continuous outcomes.

Authors:  James M S Wason; Adrian P Mander; Simon G Thompson
Journal:  Stat Med       Date:  2011-12-05       Impact factor: 2.373

2.  Statistical evaluation of improvement in RNA secondary structure prediction.

Authors:  Zhenjiang Xu; Anthony Almudevar; David H Mathews
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

3.  Some recommendations for multi-arm multi-stage trials.

Authors:  James Wason; Dominic Magirr; Martin Law; Thomas Jaki
Journal:  Stat Methods Med Res       Date:  2012-12-12       Impact factor: 3.021

4.  An optimised multi-arm multi-stage clinical trial design for unknown variance.

Authors:  Michael J Grayling; James M S Wason; Adrian P Mander
Journal:  Contemp Clin Trials       Date:  2018-02-21       Impact factor: 2.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.